World's Best Scientists 2026 revealed!
Thierry VandenDriessche

Thierry VandenDriessche

D-Index & Metrics

Biology and Biochemistry

D-Index
62
Citations
13337
World Ranking
10828
National Ranking
195

Thierry VandenDriessche publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Thierry VandenDriessche sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 227 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Thierry VandenDriessche D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Thierry VandenDriessche sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 62 D-Index — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Cancer

Thierry VandenDriessche mainly investigates Genetic enhancement, Virology, Molecular biology, Immunology and Viral vector. Thierry VandenDriessche has researched Genetic enhancement in several fields, including Vector, In vivo and Cell biology. His studies deal with areas such as Insertional mutagenesis, Transgene and Mutation as well as Virology.

The Molecular biology study combines topics in areas such as RNA, Gene, Mutant, Green fluorescent protein and Bone marrow. His Immunology study incorporates themes from Severe combined immunodeficiency and Gene delivery. His research combines Ex vivo and Viral vector.

His most cited work include:

  • Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions (1431 citations)
  • Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates (609 citations)
  • Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism (401 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Genetic enhancement, Immunology, Viral vector, Virology and Factor IX. His work investigates the relationship between Genetic enhancement and topics such as Cancer research that intersect with problems in Transfection. His Immunology research is multidisciplinary, incorporating perspectives in Clinical trial and In vivo.

His research in Viral vector intersects with topics in Molecular biology, Computational biology, Gene expression and Transduction. His Factor IX study results in a more complete grasp of Internal medicine. Thierry VandenDriessche interconnects Clotting factor and Stem cell in the investigation of issues within Gene delivery.

He most often published in these fields:

  • Genetic enhancement (78.71%)
  • Immunology (37.75%)
  • Viral vector (38.15%)

What were the highlights of his more recent work (between 2016-2021)?

  • Genetic enhancement (78.71%)
  • Viral vector (38.15%)
  • Gene (21.69%)

In recent papers he was focusing on the following fields of study:

Genetic enhancement, Viral vector, Gene, Bioinformatics and Factor IX are his primary areas of study. His Genetic enhancement study combines topics from a wide range of disciplines, such as Vector, Adeno-associated virus, Computational biology and Transgene. His research integrates issues of Promoter and Gene expression in his study of Transgene.

His Gene study improves the overall literature in Genetics. His Factor IX research incorporates themes from Vector, Antigen, Spleen, Hemophilias and Knockout mouse. His work carried out in the field of Transposable element brings together such families of science as Cellular differentiation and Induced pluripotent stem cell.

Between 2016 and 2021, his most popular works were:

  • Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells. (38 citations)
  • Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells. (38 citations)
  • A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice (36 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Cancer

Thierry VandenDriessche mainly focuses on Viral vector, Genetic enhancement, Muscle disorder, Gene expression and Transgene. Thierry VandenDriessche has included themes like Bioinformatics, Transposable element, Transposase and Virology in his Viral vector study. His Transposable element study integrates concerns from other disciplines, such as Transfection and Induced pluripotent stem cell.

His study explores the link between Genetic enhancement and topics such as Computational biology that cross with problems in Cellular differentiation. His biological study spans a wide range of topics, including MBNL1, CRISPR, Follistatin, Promoter and Transduction. His Gene expression research is multidisciplinary, relying on both Haematopoiesis and Immune system, Antibody, Immune tolerance, Immunology.

Best Publications

  • Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

    Peter Carmeliet;Lieve Moons;Aernout Luttun;Valeria Vincenti

  • Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates

    Lajos Mátés;Marinee K L Chuah;Eyayu Belay;Boris Jerchow

  • Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism

    Julián Aragonés;Martin Schneider;Martin Schneider;Martin Schneider;Katie Van Geyte;Katie Van Geyte;Peter Fraisl;Peter Fraisl

  • Recent Advances in Lentiviral Vector Development and Applications

    Janka Mátrai;Marinee K L Chuah;Thierry VandenDriessche

  • Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo

    Thierry VandenDriessche;Lieven Thorrez;Luigi Naldini;Antonia Follenzi

  • Nanoparticles for the delivery of genes and drugs to human hepatocytes

    Tadanori Yamada;Yasushi Iwasaki;Hiroko Tada;Hidehiko Iwabuki

  • Comparative analysis of transposable element vector systems in human cells

    Ivana Grabundzija;Markus Irgang;Lajos Mátés;Eyayu Belay

  • Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice

    Thierry VandenDriessche;Veerle Vanslembrouck;Inge Goovaerts;Hans Zwinnen

  • Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy.

    T. Vandendriessche;L. Thorrez;A. Acosta-Sanchez;I. Petrus

  • Codon optimization of human factor VIII cDNAs leads to high-level expression

    Natalie J. Ward;Suzanne M. K. Buckley;Simon N. Waddington;Thierry VandenDriessche;Thierry VandenDriessche

  • Challenges with advanced therapy medicinal products and how to meet them

    Christian K. Schneider;Paula Salmikangas;Bernd Jilma;Bruno Flamion

  • Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors

    Marinee K L Chuah;Gudrun Schiedner;Lieven Thorrez;Brian Brown

  • Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation

    Melvin Y. Rincon;Thierry VandenDriessche;Thierry VandenDriessche;Marinee K. Chuah;Marinee K. Chuah

  • Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells

    Thierry VandenDriessche;Zoltán Ivics;Zsuzsanna Izsvák;Marinee K. L. Chuah

  • Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants

    Jonas Weinmann;Sabrina Weis;Josefine Sippel;Warut Tulalamba

  • Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice

    Marinee K.L. Chuah;An Van Damme;Hans Zwinnen;Inge Goovaerts

  • Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk

    Janka Mátrai;Alessio Cantore;Cynthia C. Bartholomae;Andrea Annoni

  • Differential Effects of Progenitor Cell Populations on Left Ventricular Remodeling and Myocardial Neovascularization After Myocardial Infarction

    Christophe Dubois;Xiaoshun Liu;Piet Claus;Glenn Marsboom

  • Efficient Lentiviral Transduction and Improved Engraftment of Human Bone Marrow Mesenchymal Cells

    An Van Damme;Lieven Thorrez;Ling Ma;Herman Vandenburgh;Herman Vandenburgh

  • Recent Advances in Lentiviral Vector Development and Applications (vol 18, pg 477, 2010)

    Janka Matrai;Marinee Chuah;Thierry Vandendriessche

Frequent Co-Authors

Marinee Chuah
Marinee Chuah KU Leuven
Desire Collen
Desire Collen KU Leuven
Luigi Naldini
Luigi Naldini Vita-Salute San Raffaele University
Zsuzsanna Izsvák
Zsuzsanna Izsvák Max Delbrück Center for Molecular Medicine
David Lillicrap
David Lillicrap Queen's University
Herman H. Vandenburgh
Herman H. Vandenburgh Brown University
George Dickson
George Dickson Royal Holloway University of London
Eugenio Montini
Eugenio Montini IRCCS Ospedale San Raffaele

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Thierry VandenDriessche

Trending Scientists